These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39084066)

  • 1. Serum interleukin-18 levels can improve the diagnostic performance of the PRINTO and ILAR criteria for systemic juvenile idiopathic arthritis.
    Kaneko S; Shimbo A; Irabu H; Mizuta M; Nakagishi Y; Iwata N; Yokoyama K; Yasumura J; Akamine K; Ueno K; Fujita S; Watanabe K; Watanabe S; Nishikawa H; Fujimura J; Mori M; Shimizu M
    Cytokine; 2024 Oct; 182():156719. PubMed ID: 39084066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlap of International League of Associations for Rheumatology and Preliminary Pediatric Rheumatology International Trials Organization Classification Criteria for Nonsystemic Juvenile Idiopathic Arthritis in an Established UK Multicentre Inception Cohort.
    Shoop-Worrall SJW; Macintyre VG; Ciurtin C; Cleary G; McErlane F; Wedderburn LR; ; Hyrich KL
    Arthritis Care Res (Hoboken); 2024 Jun; 76(6):831-840. PubMed ID: 38212149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of International League of Associations for Rheumatology and Pediatric Rheumatology International Trials Organization Classification Systems for Juvenile Idiopathic Arthritis Among Children in a Canadian Arthritis Cohort.
    Lee JJY; Eng SWM; Guzman J; Duffy CM; Tucker LB; Oen K; Yeung RSM; Feldman BM;
    Arthritis Rheumatol; 2022 Aug; 74(8):1409-1419. PubMed ID: 35289119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of recent PRINTO criteria versus current ILAR criteria for systemic juvenile idiopathic arthritis: A single-centre experience.
    Koker O; Demirkan FG; Cakmak F; Aktay Ayaz N
    Mod Rheumatol; 2023 Jan; 33(1):187-193. PubMed ID: 34850131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study.
    Kaya Akca U; Batu ED; Sener S; Balik Z; Kasap Cuceoglu M; Atalay E; Basaran O; Bilginer Y; Ozen S
    Clin Rheumatol; 2022 Jun; 41(6):1785-1792. PubMed ID: 35091782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the new PRINTO classification criteria for juvenile idiopathic arthritis in a sample of Portuguese patients.
    Catarino S; Nunes J; Ganhão S; Aguiar F; Rodrigues M; Brito I
    ARP Rheumatol; 2024; 3(1):11-17. PubMed ID: 38558063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis.
    Mizuta M; Shimizu M; Inoue N; Ikawa Y; Nakagishi Y; Yasuoka R; Iwata N; Yachie A
    Rheumatology (Oxford); 2021 May; 60(5):2421-2426. PubMed ID: 33200207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism.
    Berntson L; Fasth A; Andersson-Gäre B; Kristinsson J; Lahdenne P; Marhaug G; Nielsen S; Pelkonen P; Svensson E;
    J Rheumatol; 2001 Dec; 28(12):2737-43. PubMed ID: 11764226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study.
    Kunjir V; Venugopalan A; Chopra A
    J Rheumatol; 2010 Aug; 37(8):1756-62. PubMed ID: 20516021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children.
    Merino R; De Inocencio J; García-Consuegra J
    J Rheumatol; 2001 Dec; 28(12):2731-6. PubMed ID: 11764225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
    Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001).
    Merino R; de Inocencio J; García-Consuegra J
    J Rheumatol; 2005 Mar; 32(3):559-61. PubMed ID: 15742453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus.
    Martini A; Ravelli A; Avcin T; Beresford MW; Burgos-Vargas R; Cuttica R; Ilowite NT; Khubchandani R; Laxer RM; Lovell DJ; Petty RE; Wallace CA; Wulffraat NM; Pistorio A; Ruperto N;
    J Rheumatol; 2019 Feb; 46(2):190-197. PubMed ID: 30275259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Challenges and Opportunities of Classifying Childhood Arthritis.
    Rumsey DG; Laxer RM
    Curr Rheumatol Rep; 2020 Jan; 22(1):4. PubMed ID: 31927650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations in the classification of childhood-onset rheumatoid arthritis.
    Ferrell EG; Ponder LA; Minor LS; Angeles-Han ST; Kennedy CW; Rouster-Stevens KA; Rohani-Pichavant M; Vogler LB; Prahalad S
    J Rheumatol; 2014 Mar; 41(3):547-53. PubMed ID: 24488421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients.
    Thomson W; Barrett JH; Donn R; Pepper L; Kennedy LJ; Ollier WE; Silman AJ; Woo P; Southwood T;
    Rheumatology (Oxford); 2002 Oct; 41(10):1183-9. PubMed ID: 12364641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
    Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Pediatr Res; 2020 Dec; 88(6):934-939. PubMed ID: 32184444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focus on juvenile idiopathic arthritis according to the 2001 Edmonton revised classification from the International League of Associations for Rheumatology: an Italian experience.
    Stabile A; Avallone L; Compagnone A; Ansuini V; Bertoni B; Rigante D
    Eur Rev Med Pharmacol Sci; 2006; 10(5):229-34. PubMed ID: 17121315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis.
    Stoll ML; Lio P; Sundel RP; Nigrovic PA
    Arthritis Rheum; 2008 Jan; 59(1):51-8. PubMed ID: 18163407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis.
    Jelusić M; Lukić IK; Tambić-Bukovac L; Dubravcić K; Malcić I; Rudan I; Batinić D
    Clin Rheumatol; 2007 Aug; 26(8):1332-4. PubMed ID: 17597334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.